Community-Associated Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections

Disease-a-Month

Volumn 54, Issue 12, 2008, Pages 780-786

  Whitman, Timothy J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; LINEZOLID; MINOCYCLINE; PENICILLIN G; PSEUDOMONIC ACID; RIFAMPICIN; VIRULENCE FACTOR;

ABSCESS DRAINAGE; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; BACTERIAL COLONIZATION; BACTERIAL SKIN DISEASE; CLINICAL FEATURE; COMMUNITY ASSOCIATED STAPHYLOCOCCUS INFECTION; DIAGNOSTIC ACCURACY; ENVIRONMENTAL SANITATION; EPIDEMIOLOGICAL DATA; HOSPITAL ADMISSION; HOST PATHOGEN INTERACTION; HUMAN; INCISION; INFECTION PREVENTION; INFECTION RISK; MEDICAL DECISION MAKING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; REVIEW; RISK ASSESSMENT; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INCIDENCE; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RISK FACTORS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; UNITED STATES;

EID: 55249099766     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2008.09.010     Document Type: Review

References (27)

1. Finch R. Skin and soft tissue infections. Lancet 1 (1988) 164-168
2. Charlebois E.D., Perdreau-Reminton F., Kreiswirth B., et al. Origins of community strains of methicillin-resistant Staphyloccus aureus. Clin Infect Dis 39 (2004) 47-54
3. Moran G.J., Krishnadasan A., Gorwitz R.J., et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355 (2006) 666-674
4. Garnier F., Tristan A., Francois B., et al. Pneumonia and new methicillin-resistant Staphylococcus aureus clone. Emerg Infect Dis 12 (2006) 498-500
5. Fridkin S.K., Hageman J.C., Morrison M., et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 352 (2005) 1436-1444
6. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison: Mississippi, 2000. MMWR Morb Mortal Wkly Rep 50 (2001) 919-922
7. Miller L.G., Perdreau-Remington F., Reig G., et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352 (2005) 1445-1453
8. Kline M.D., Humphrey B.S., Wang Y.F., et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft tissue infections. Ann Intern Med 144 (2006) 309-317
9. Kazakova S.V., Hageman J.C., Matava M., et al. A clone of methicillin-resistant Staphylococcus aureus among Professional Football Players. N Engl J Med 352 (2005) 468-475
10. Petrucelli B., Rubertone M.V., Brundage J.F., et al. Cellulitis and abscess, Active Components, US Armed Forces, 2002-2005. Medical Surveillance Monthly Report US Army Center for Health Promotion and Preventative Medicine 12 (2006) 2-8
11. McDougal L.K., Steward C.D., Killgore G.E., et al. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States; establishing a national database. J Clin Microbiol 41 (2003) 5113-5120
12. Yamasaki O., Kaneko J., Morizane S., et al. The association between Staphylococcus aureus strains carrying Panton-Valentine leukocidin genes and the development of deep-seated follicular infection. Clin Infect Dis 40 (2005) 381-385
13. Voyich J.M., Otto M., Mathema B., et al. Is Panton-Valentine Leukocidin the major virulence determinant in community-associated methicillin resistant Staphylococcus aureus disease?. J Infect Dis 194 (2006) 1761-1770
14. Wertheim H.F., Melles D.C., Vos M.C., et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 5 (2005) 751-762
15. Ellis M.W., Hospenthal D.R., Dooley D.P., et al. Natural history of community-acquired methicillin-resistant Staphyloccus aureus colonization and infection in soldiers. Clin Infect Dis 39 (2004) 971-979
16. von Eiff C., Becker K., Machka K., et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med 344 (2001) 11-16
17. Perl T.M., Cullen J.J., and Wenzel R.P. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 346 (2002) 1871-1877
18. Ellis M.W., Griffith M.E., Dooley D.P., et al. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin resistant staphylococcus aureus strains in soldiers: a cluster randomized controlled trial. Antimicrob Agents Chemother 51 (2007) 3591-3598
19. Miller L.G., and Diep A.D. Colonization, fomites and virulence: rethinking the pathogenesis of community-associated methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis 46 (2008) 752-760
20. Campbell K.M., Vaughn A.F., Russell K.L., et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California in 2002. J Clin Microbiol 42 9 (2004) 4050-4053
21. Turabelidze G., Lin M., Wolkoff B., et al. Personal hygiene and methicillin-resistant Staphylococcus aureus infection. Emerg Infect Dis 10 (2004) 941-944
22. Shastry L., Rahimian J., and Lascher S. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections in men who have sex with men in New York City. Arch Intern Med 167 (2007) 854-857
23. Minnesota Department of Health. Community-associated methicillin resistant Staphylococcus aureus in Minnesota. Minnesota Department of Heath Disease Control Newsletter 32 (2004) 61-72
24. Grayson L.M. The treatment triangle for Staphylococcal infections. N Engl J Med 355 (2006) 724-726
25. Lee M.C., Rios A.M., Aten M.F., et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 23 (2004) 123-127
26. Moellering R.C. A 39-year-old man with skin infection. J Am Med Assoc 299 (2008) 79-87
27. Weigelt J., Kaafarani H.M., Itani K.M., et al. Linezolid eradicates MRSA better than vancomycin from surgical-site infections. Am J Surg 188 (2004) 760-766